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Introduction
Schizophrenia is a chronic and debilitating mental disease 
from which about 1% of the world’s population suffer (1). 
Ketamine, an anesthetic drug in veterinary and medical 
surgery (antagonist of the glutamatergic N-methyl-d-
aspartate [NMDA] receptors) is applied to induce some 
symptoms of schizophrenia in animal models. Ketamine 
can cause hallucinatory effects in human as well, so it is 
used as a common recreational drug among abusers (2, 
3). At sufficiently high doses, subjects may experience 
a state of dissociation called the “K-hole”, supposed to 
mimic the phenomenology of schizophrenia (4). Besides 
the toxicity to the nervous system, ketamine can affect the 
lower urinary tract, causing dysuria, polyuria, hematuria, 
nocturia, and decreased sperm motility and quality (5,6). 
The results of several studies suggest that patients with 
schizophrenia, especially men, have lower fertility rates 
compared to healthy subjects (7).
There are evidences suggesting that reactive oxygen 
species (ROS) are involved in membranous pathologies 
of central nervous system and may have an important 
role in neuropsychiatric disorders like schizophrenia (8). 
Interestingly, excess amounts of free oxygen radicals also 
can induce production of abnormal sperms and result in 
infertility (9).
Carvacrol (CAR), [2-Methyl-5-(1-methylethyl)], a 
monoterpenic phenol found in many essential oils of the 
family Labiatae, such as Origanum, Satureja, Thymbra, 
Thymus, and Coridothymus species (10), possesses free 
radical scavenging activity. Some authors demonstrated its 
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Introduction: Ketamine is applied to induce symptoms of schizophrenia in animal models. 
Besides the nervous system, ketamine also affects male lower genitourinary tracts. The present 
study evaluated the effects of carvacrol on antioxidant enzymes and examined the histopathologic 
changes in the testes of ketamine induced schizophrenic mice. 
Methods: A total of 48 male mice were treated with 25 mg/kg ketamine or saline for a period of 14 
days. Between the 8th and 14th days, the animals received carvacrol (25 and 50 mg/kg) or saline. 
At the end of the experiment, blood samples were taken to measure luteinizing hormone (LH), 
follicle-stimulating hormone (FSH) and testosterone; the testes were also collected for biochemical 
and histopathological evaluations. 
Results: The results indicated that induction of schizophrenia by ketamine led to an oxidative 
stress by increasing malondialdehyde (MDA) level (P < 0.05). Treatment with 50 mg/kg carvacrol 
resulted in significant decrease in oxidative injury by decreasing MDA level and increasing 
antioxidant enzymes (P < 0.05). Testosterone, FSH and LH levels showed no significant difference 
between treatment groups and control groups except for testosterone which increased in mice 
treated with 50 mg/kg carvacrol (P < 0.05). Administration of carvacrol reduced the deleterious 
histopathologic changes caused by ketamine. 
Conclusion: The present study showed that ketamine causes oxidative stress and damage in 
testicular tissues and co-administration with carvacrol prevents the harmful effects of ketamine. 
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protective effect on the nervous system and testis (11,12). 
The US Food and Drug Administration (FDA) approved 
carvacrol to be used in food processing as an additive 
(13). The aim of the present study was to investigate 
the effects of ketamine on biochemical parameters of 
oxidative stress damage and histopathological alterations 
in testicular tissues of mice and also to evaluate the effects 
of co-administration of carvacrol as a potent and safe 
radical scavenger on antioxidant enzyme activities and 
on the levels of lipid peroxidation in the testicular tissues 
of schizophrenic mice. To our knowledge, this is the first 
study investigating the biochemical and histopathological 
effects of carvacrol on schizophrenic mice testes.
Material and Methods
Animals and experimental design
Forty-eight adult male Swiss albino mice (25-35 g) aging 
about 2 months were purchased from the Pasteur Institute 
of Iran (North research center, Amol, Iran) and were 
randomly allocated into 6 groups. Animals were allowed to 
adapt to the new condition for a week. They were housed 
in groups of three or four in temperature-controlled 
rooms (24°C) with constant humidity (55 ± 10%) and 12-
hour light/dark cycle prior to undergoing experimental 
protocols. They accessed commercial rodent chow (Pars, 
Tehran, Iran) and water ad libitum. All experiments were 
performed at the same time of the day. 
Chemicals 
Carvacrol, C10H14O with a molecular weight of 150.22, 
was purchased from Sigma (Sigma-Aldrich, Germany). 
According to Sigma, the degree of purity was >97%. 
Tween 80 (Sigma, USA), ketamine (Alfasan, Woerden, 
Holland) and all the other chemicals were analytical grade 
and commercially available. Carvacrol was emulsiﬁed 
with 0.2% Tween 80 and dissolved in distilled water.
Treatment protocol
The animals received 25 mg/kg ketamine or saline 
intraperitoneally (i.p.) for 14 days (14). Between the 8th 
and 14th days, the animals received carvacrol (25 and 50 
mg/kg, i.p.) or saline. This research design was led to 6 
experimental groups, as follows:
1) saline plus saline (as control group); 2) ketamine plus 
saline (called ketamine group); 3) saline plus carvacrol 25 
mg/kg (called carvacrol 25 group); 4) saline plus carvacrol 
50 mg/kg (called carvacrol 50 group); 5) ketamine plus 
carvacrol 25 mg/kg (called ketamine + carvacrol 25 
group); and 6) ketamine plus carvacrol 50 mg/kg (called 
ketamine + carvacrol 50).
Biochemical analysis
At the end of the experiment, blood samples were collected 
from mice for measuring luteinizing hormone (LH), 
follicle-stimulating hormone (FSH) and testosterone; 
sera were separated by centrifuging the samples at 4000 
rpm for10 minutes. Levels of serum testosterone, LH and 
FSH were assayed using automated chemiluminescence 
immunoassay systems (ADVIA Centaur, Bayer Vital, 
Fernwald, Germany).
Histopathological analysis
After excising the testicular tissues of the euthanized 
mice, sections of the testis were fixed in 10% formalin 
and were embedded in paraffin wax. Sections were then 
cut at a 5-µm thickness, deparaffinized and stained with 
hematoxylin and eosin (H&E) according to the standard 
methods. For histopathological evaluation, eight sections 
from each testicular tissue were examined by a pathologist 
who was blinded to the study groups.
Tissue preparation
The testicular tissue was collected and rinsed with ice-cold 
saline and stored at -80°C. Before biochemical analysis, 
the tissue from testis was homogenized at 4°C after adding 
pre-cooled 0.9% saline in a ratio of 1:9. When testicular 
tissue was disrupted; the homogenate was centrifuged at 
3000 × g for 10 minutes at 4°C. The supernatant was used 
for biochemical measurements. Protein content of the 
tissue homogenate was determined using a colorimetric 
method of Lowry with bovine serum albumin as the 
standard (14).
Determination of malondialdehyde 
The formation of thiobarbituric acid in organ samples was 
assessed to measure the lipid peroxidation according to an 
original method (15). Briefly, the supernatant of the tissue 
homogenate was mixed with 20% trichloroacetic acid and 
the mixture was centrifuged. Then, thiobarbituric acid 
was added to the supernatant and heated. The absorbance 
of the supernatant was measured at 532 nm. 
Catalase 
A 10% tissue homogenate was prepared in 2 mL of 
potassium phosphate buffer (pH 7.4). This homogenate 
was centrifuged at 3000 rpm for 15 minutes. Catalase 
activity was measured in the supernatant obtained after 
centrifugation. 2.95 mL of 19 mM H2O2 was poured in 
the cuvette. To it, 0.05 mL of cytosolic supernatant was 
added and the change in absorbance at 240 nm was 
recorded at 1 minute intervals for 3 minutes, knowing that 
the presence of catalase decomposes H2O2 leading to a 
decrease in absorbance (16). 
Total antioxidant power 
The total antioxidant capacity was determined by the ferric 
reducing antioxidant power (FRAP). Briefly, the stocks’ 
solutions included 300 Mm acetate buffer 10 mM TPTZ 
(2, 4.6-tripyridyl-s-triazine) solution in 40 mMHCl and 
20 mM FeCl3.6H2O solution. The fresh working solution 
(FRAP reagent) was prepared by mixing acetate buffer, 
TPTZ solution, and FeCl3.6H2O solutions. The samples 
and deionized water were mixed with 3 mL of the FRAP 
reagent and allowed to react for 5 minutes in the dark. The 
changes in absorbance at 593 nm were considered to be 
related to the total reducing power of antioxidants of the 
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tissues (17). 
Statistical analysis
Values are presented as mean ± SEM. The statistical 
differences between groups were applied by one-way 
analysis of variance (ANOVA), followed by Duncan’s 
test when appropriate. A P value of 0.05 was considered 
significant.
Results
Histopathological results
In the control group, seminiferous tubules were surrounded 
by dense interstitial tissue. These tubules showed round 
or oval structures. Different stages of spermatogenesis 
were identified; Spermatogonial cells, spermatocytes, 
spermatids (different steps) and spermatozoa and also 
Sertoli cells were identified. Mature spermatozoa occupied 
most of the central luminal portion of the seminiferous 
tubules. Interstitial tissue was filled with Leydig cells, 
blood vessels, fibroblasts and collagen fibers (Figure 1A).
Compared to the control group, there were significant 
pathological changes in the testicular tissues in the ketamine 
25 group. In this group, most seminiferous tubules showed 
significant derangement and morphological changes of 
different cell lines. Affected seminiferous tubules lost 
their typical spherical shapes and were wrinkled with an 
irregular basement membrane, which indicated tubular 
atrophy, however, some tubules were preserved. The 
spermatogenic cells showed degeneration and/or necrosis. 
The most commonly affected cells were spermatocytes and 
spermatids, however, some spermatogonial cells were also 
affected. Sloughed germ cells filled the lumens of tubules. 
Some multinucleated giant cell and also cytoplasmic mass 
were formed within the lumen. Some tubules showed 
severe epithelial atrophy and were only covered by Sertoli 
cells and spermatogonia and an arrest of spermatogenesis 
process was seen. These tubules had distended lumens 
compared to normal tubules. Some Sertoli cells showed 
vacuolization and swelling and necrotic cell debris were 
seen in the cytoplasm of some of them. In the interstitial 
tissue and under the tunica alboginae, vascular congestion 
was observed and in some areas reduced number of Leydig 
cells was present (Figure 1B and C).
In the carvacrol 25 group, there were no significant 
pathological changes in the testicular tissues compared 
to the control group. In detail, normal spermatogenic 
cells, Sertoli cells and well-delineated tubular basement 
membrane were seen. The interstitial tissue and Leydig 
cells were intact (Figure 1D). In the carvacrol 50 group, 
histopathological evaluation showed normal structures 
Figure 1. (A) Testicular sections of control group. Note to the normal spermatogenesis and the normal cell arrangement in the seminiferous 
tubules. The interstitial spaces also appear normal. (B and C) Photograph of testes treated with ketamine.  B: Note to the damaged 
seminiferous tubules. The seminiferous tubular epithelium is irregular and degenerated. Damaged tubules containing degenerated 
spermatogenic cell. Lumen is full of cellular and spermatogenic debris. C: Note the degeneration of spermatogenic cells and the separation 
of spermatogenic cells from the basement membrane in some tubules in this group, with giant cell formation within lumen. Degeneration of 
interstitial tissue, interstitial edema and atrophy of Leydig cell also occurred. (D) Testis of mice in carvacrol 25 group. Seminiferous tubules 
more or less are similar to that of control. (E) Note to the normal aspect of the seminiferous tubules, without microscopic alterations in 
structure in carvacrol 50. (F) Pathologic changes in seminiferous tubules had partly ameliorated and restoration of spermatogenic cells 
in most seminiferous tubules is seen. However mild vacuoles still exist within cells in ketamine + carvacrol 25 (G) Testes of the mice in 
ketamine + carvacrol 50 group, showing nearly normal mature active seminiferous tubules with complete spermatogenic series. H&E.
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similar to the control and carvacrol 25 groups (Figure 
1E). In ketamine + carvacrol 25 group, pathologic 
changes in seminiferous tubules were partly ameliorated, 
but the number of spermatozoa within the lumen was 
yet less than the control group. Vacuolization of the 
seminiferous epithelium was also seen (Figure 1F). In 
ketamine + carvacrol 50 group, histopathological changes 
were reduced remarkably. Spermatogenic cells within 
these tubules had normal stratification and relatively in 
most of the tubules all stages of spermatogenesis were 
normal, however slight degeneration (vacuolization and 
some sloughed germ cells) was observed in a few tubules 
(Figure 1G).
Biochemical results
According to the results illustrated in Table 1 the testicular 
malondialdehyde (MDA) levels in the ketamine group 
were significantly higher than those of the control group 
(P < 0.01). In the groups which received 25 and 50 mg/
kg carvacrol, no significant difference was found in the 
testicular MDA levels compared to the control group 
(P > 0.05). In the animals receiving 50 mg/kg carvacrol plus 
ketamine (ketamine+ carvacrol 50 group), the testicular 
MDA levels were revealed to be closer to the control 
group and showed significant difference in comparison 
to ketamine group (P < 0.01). Lower levels of total 
antioxidant power (TAP) were obtained in the ketamine 
(schizophrenic) group compared to the control group but 
the difference was not statistically significant. Moreover, 
the ketamine + carvacrol 50 and ketamine + carvacrol 
25 showed a significantly higher TAP level compared to 
the ketamine group (P < 0.05). There was no significant 
difference in CAT levels in comparison between the 
ketamine group and the control mice (P > 0.05), while the 
carvacrol 50, the ketamine + carvacrol 25 and ketamine + 
carvacrol 50 presented higher levels of CAT compared to 
the control group (P < 0.05).
An increase was seen in the testosterone levels of the 
group receiving 50 mg/kg carvacrol and animals treated 
with ketamine + carvacrol 50 (P < 0.05). There was no 
significant difference in LH and FSH levels between the 
treated groups  (Table 2) (P > 0.05).
Discussion
In the present study, both biochemical and histopathological 
examinations indicated that ketamine induced a marked 
reproductive toxicity through induction of oxidative stress 
which was prevented by co-administration of carvacrol. 
Even though effects of oxidative stress on testicular 
tissues were demonstrated in several studies (18-22), 
research on the effects of schizophrenia on oxidant levels 
and the expression of antioxidant enzymes in testicular 
tissues is sparse in literature. Both the male and female 
genital systems are rich in enzymatic and non-enzymatic 
antioxidants. Imbalance in oxidant/anti-oxidant status 
could cause molecular and genetic defects leading to 
infertility (23). ROS can reduce male fertility by damaging 
the sperms’ cellular membrane. These incidents can reduce 
sperm functionality through impairment of metabolism, 
motility, acrosomal reactivity, fusogenic capacity, and 
damage to the DNA of sperm (6,24,25). In some studies, 
it was shown that the antioxidants levels in the blood were 
correlated with spermatic counts and motility (5,26,27). In 
the present study, an increase in lipid peroxidation (MDA) 
and reduction in TAP in the testes of schizophrenic group 
(following ketamine administration at a dose of 25 mg/
Table 2. Determination of testosterone, FSH and LH in different treatment groups
Groups Testosterone (ng/mL) FSH (ng/mL) LH (ng/mL)
Control 2.25± 0.06 0.28± 0.02 0.27± 0.04
Ketamine 2.05± 0.05 0.27± 0.05 0.26± 0.03
Carvacrol 25 2.45± 0.03 0.22± 0.04 0. 26± 0.02
Carvacrol 50 3.00± 0.09a 0.23± 0.02 0.25± 0.02
Ketamine + Carvacrol 25 2.47± 0.05 0.27± 0.04 0.28± 0.06
Ketamine + Carvacrol 50 3.03± 0.06a 0.25± 0.04 0.25± 0.03
Data are presented as Mean ± SEM. 
a Significantly different  from ketamine group as P < 0.05.
Table 1. Determination of malondialdehyde, catalase and total antioxidant power in different treatment groups
Groups MDA  (nmol/mg protein) CAT (U/mg  protein) TAP (mmol/mg  protein)
Control 15.50 ± 0.19 33.19± 3.64 255.4±18.08
Ketamine 27.5± 3.28a 34.83±7.75 239.6±11.40
Carvacrol 25 21.58± 0.58 38.92±4.02 260±11.40
Carvacrol 50 19.65± 0.92 54.14±4.10c 276±59.80
Ketamine + Carvacrol 25 24.17± 1.64 54.41±4.95c 359.2±57.39b
Ketamine + Carvacrol 50 18.22± 1.41b 51.60±3.38c 392±34.40b
Data are presented as Mean ± SEM. 
a Significantly different  from control group as P < 0.01; b Significantly different  from ketamine group as P < 0.05; c Significantly different  from control 
group as P < 0.05.
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kg for 2 weeks) clearly demonstrated the failure in the 
antioxidant defense system. These result were compatible 
with Ozyurt et al who induced schizophrenia in rats by 
dizocilpine (MK-801) and showed a significant oxidative 
stress by increasing super oxide dismutase in the testes (18). 
They also reported increase in tissue MDA and protein 
carbonyl levels. Parlaktas et al evaluated the effects of 
melatonin on oxidative stress and histopathologic changes 
in testis of MK-801-induced psychosis rat model. They 
demonstrated MDA, protein carbonyl and NO levels were 
increased in testicular tissues of rats and treatment with 
melatonin led to significant decrease in oxidative injury 
(28). Data obtained in the present study showed increase 
in MDA level in testes of mice treated with ketamine and 
co-administration of carvacrol led to significant decrease 
in MDA levels.
Absalan et al reported that a decrease in membrane 
integrity might be a result of ROS function induced by 
ketamine. CAT, which prevents ROS damage, has been 
found in both human testis and spermatozoa (6). An 
increase in free radical formation leads to compensatory 
mechanisms characterized by higher activity of the free 
radical scavenging enzymes such as CAT (29). Various 
researches have indicated lower, normal or elevated 
catalase activity in schizophrenic human patients’ sera 
(30,31). However, in the present study CAT activity in the 
testes of mice receiving ketamine (schizophrenic model) 
did not change significantly (P > 0.05). 
Lower testosterone, LH and FSH levels have been reported 
in patients with schizophrenia (32-34), although recent 
surveys detected that the serum testosterone levels showed 
no difference between schizophrenic and healthy subjects 
(35,36). This is in concordance with the results obtained 
from the present study which showed no significant 
changes in testosterone, LH and FSH in schizophrenic 
mice model. 
Carvacrol possesses significant antioxidant properties. 
Potent antimutagenic and antioxidant effects of carvacrol 
have been demonstrated by in vitro (37,38) and in vivo 
studies (39). Haeri et al showed that administration 
of essential oil of Satureja khuzestanica (SKEO) (225 
mg/kg) that contains carvacrol to male rats increases 
FSH and testosterone, and improves the weights of 
testes, epididymides, and accessory sex glands (40). 
Histopathological analysis also showed that in male 
rats treated with SKEO (150, 225 mg/kg), the number 
of spermatogonium, spermatids, spermatozoids and 
Leydig cells increased and the Sertoli cells underwent 
hypertrophy. These findings were compatible with our 
study; however we showed protective effects of carvacrol 
especially at a dose of 50 mg/kg in ketamine induced 
model of schizophrenia.
Satureja montana extract, containing carvacrol as a 
major component (79.75%), resulted in an increase in 
testosterone levels in rats. However, it led to no significant 
alteration in serum LH and FSH levels (41). Similar pattern 
of alterations in FSH, LH and testosterone levels in rats 
that received Iranian S. khuzestanica essential oil, mainly 
containing carvacrol (93.9%), was reported by Rezvanfar 
et al (42). The evidences presented in our study are in 
accordance with aforementioned studies; we illustrated an 
increase in the testosterone level in the carvacrol 50 and 
ketamine + carvacrol 50 groups, with no changes in LH 
and FSH levels.
Daggulli et al (12) demonstrated that carvacrol decreased 
MDA levels in serum, and testicular tissue which was 
elevated through methotrexate therapy. In line with 
the mentioned study, in the present study, carvacrol 50 
mg/kg along with ketamine caused a decrease of lipid 
peroxidation in the testis. So carvacrol may protect germ 
cells against oxidative stress and apoptosis.
Conclusion
Although the precise mechanism of oxidative stress as a 
result of ketamine treatment has not been clarified in the 
present study, the results of histologic and biochemical 
analysis support that an oxidative injury occurred in 
testicular tissues of mice. Our results suggest that oxidative 
stress exerted on testicular tissues by ketamine was 
reversed by carvacrol. Further experimental and clinical 
studies are needed to fully understand the mechanism of 
action of carvacrol.
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